glp-1 news oct 16 2025 obesity drug today october What's next for innovation: A primer on the race reshaping pharma and chronic disease care New Daily GLP-1 Weight Loss – GLP-1 Drugs and Consumer Preferences:

Several key sequence features underpin the triple receptor agonist activity of the molecule: Position 1 (Histidine) : The N-terminal histidine residue is critically important for glucagon receptor activation

Standard Capsules: Affordable but often have very low absorption rates

Market Size and Context The CPHA piece reports that about one-third of Canadian adults now live with obesity, and that the condition is associated with over $27 billion in economic costs in Canada including healthcare, productivity losses, and premature death

Metabolic Biomarkers: Utilized in controlled models measuring endocrine-linked metabolic readouts alongside pathway markers